Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BIOCHEMICAL RECURRENCE, . Treffer: 15

2019

Kardoust Parizi, M; Iwata, T; Kimura, S; Janisch, F; Abufaraj, M; Karakiewicz, PI; Enikeev, D; Rapoport, LM; Hutterer, G; Shariat, SF Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2019; 20(6): 1374 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pernthaler, B; Kulnik, R; Gstettner, C; Salamon, S; Aigner, RM; Kvaternik, H A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT.
Clin Nucl Med. 2019; 44(10): e566-e573-e566-e573.
Web of Science PubMed FullText FullText_MUG

 

2016

Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Lucca, I; Shariat, SF; Briganti, A; Lotan, Y; Roehrborn, CG; Montorsi, F; Remzi, M; Seitz, C; Fajkovic, H; Klingler, C; Karakiewicz, PI; Sun, M; Rouprêt, M; Loidl, W; Pummer, K; Klatte, T Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Urol Oncol. 2015; 33(2):71.e21-71.e26
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Faber, F; Wallwiener, D; Schilling, D; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Fehm, T; Stenzl, A; Schwentner, C Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.
Prostate. 2015; 75(6):637-645
Web of Science PubMed FullText FullText_MUG

 

2014

Kaushik, AK; Vareed, SK; Basu, S; Putluri, V; Putluri, N; Panzitt, K; Brennan, CA; Chinnaiyan, AM; Vergara, IA; Erho, N; Weigel, NL; Mitsiades, N; Shojaie, A; Palapattu, G; Michailidis, G; Sreekumar, A Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.
J Proteome Res. 2014; 13(2):1088-1100 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rieken, M; Kluth, LA; Xylinas, E; Fajkovic, H; Becker, A; Karakiewicz, PI; Herman, M; Lotan, Y; Seitz, C; Schramek, P; Remzi, M; Loidl, W; Pummer, K; Lee, RK; Faison, T; Scherr, DS; Kautzky-Willer, A; Bachmann, A; Tewari, A; Shariat, SF Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
World J Urol. 2014; 32(4):999-1005
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159
Web of Science PubMed FullText FullText_MUG

 

2013

Rieken, M; Kluth, LA; Xylinas, E; Seitz, C; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Briganti, A; Loidl, W; Faison, T; Crivelli, JJ; Scherr, DS; Bachmann, A; Tewari, AK; Kautzky-Willer, A; Pummer, K; Shariat, SF Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Prostate Cancer Prostatic Dis. 2013; 16(4):367-371
Web of Science PubMed FullText FullText_MUG

 

2010

Fuchsjager, MH; Pucar, D; Zelefsky, MJ; Zhang, ZG; Mo, QX; Ben-Porat, LS; Shukla-Dave, A; Wang, LA; Reuter, VE; Hricak, H PREDICTING POST-EXTERNAL BEAM RADIATION THERAPY PSA RELAPSE OF PROSTATE CANCER USING PRETREATMENT MRI
INT J RADIAT ONCOL. 2010; 78(3): 743-750. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Fuchsjager, MH; Shukla-Dave, A; Hricak, H; Wang, L; Touijer, K; Donohue, JF; Eastham, JA; Kattan, MW Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy
BJU INT. 2009; 104(3): 315-320.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Karakiewicz, PI; Hutterer, GC Predictive models and prostate cancer.
Nat Clin Pract Urol. 2008; 5(2):82-92
Web of Science PubMed FullText FullText_MUG

 

2007

Briganti, A; Chun, FK; Hutterer, GC; Gallina, A; Shariat, SF; Salonia, A; Scattoni, V; Valiquette, L; Montorsi, F; Rigatti, P; Graefen, M; Huland, H; Karakiewicz, PI Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Eur Urol. 2007; 52(3):733-743
Web of Science PubMed FullText FullText_MUG

 

Gallina, A; Briganti, A; Chun, FKH; Walz, J; Hutterer, GC; Erbersdobler, A; Eichelberg, C; Schlomm, T; Ahyai, SA; Perrotte, P; Saad, F; Montorsi, F; Huland, H; Graefen, M; Karakiewicz, PI Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU Int. 2007; 100(6):1249-1253 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2003

Augustin, H; Erbersdobler, A; Graefen, M; Fernandez, S; Palisaar, J; Huland, H; Hammerer, P Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
PROSTATE. 2003; 55(1): 48-54.
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum